FindTrial
Sign In

The Effectiveness of Nicergoline on prevention of acoustic trauma

The effectiveness of Nicergoline on prevention of acoustic trauma

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200519002
Enrollment
Unknown
Registered
2020-05-19
Start date
2019-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal problem liver problem anemia Nicegoline&#44

Interventions

taking Nicergoline 30mg twice daily for 2 weeks,placebo was made in similar appareance as Nicergoline drug
Experimental Drug,Placebo Comparator No treatment
Nicergoline group,Placebo group

Sponsors

Siam phamaceutical
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1normal CBC,BUN,CR,electrolyte 2normal audiogram 3Thai male age between 18-25years old with no underlying

Exclusion criteria

Exclusion criteria: 1abnormal audiogram 2abnormal lab 3allergic to sulfa-drug

Design outcomes

Primary

MeasureTime frame
hearing loss 24 hours audiogram (decibel)—

Secondary

MeasureTime frame
tinnitus 24 hr time—

Countries

Thailand

Contacts

Public ContactRongrat Pagcharoenpol

otolaryngology department Pramongkutklao Hospital

Rongrat_lk@hotmail.com0840178637

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026